Please assess the completion status of the following clinical trial:

Trial Title: Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Participants with ongoing adalimumab treatment who completed at least Month 3 (Visit 5) of NCT00448383 (Study M02-497) and who had subsequently been prescribed adalimumab according to the Summary of Product Characteristics (SmPC).~* Participants must have been willing to consent to data being collected and provided to Abbott.~Exclusion Criteria:~· Participants with contraindications according to the SmPC.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Adalimumab (Type: None): RA patients in treatment with commercial adalimumab

Based on this trial design, predict the completion outcome and termination type (if applicable).